Large Cap Biotech
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Trend Stats
1-Month Return
+7.63%
3-Month Return
-0.60%
12-Month Return
+44.82%
Volatility Score
2.0
RSI
55.7
ST Trend
Neutral
LT Trend
Up
Short-Term Trend
Neutral
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Large Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | $186B | +27.76% | +1.06% | -0.85% | 2.2 | Down | Up |
| GILD | Gilead Sciences | $165B | +29.69% | +3.82% | -2.86% | 2.4 | Down | Up |
| VRTX | Vertex Pharma | $111B | -10.99% | -5.32% | -3.83% | 2.5 | Down | Down |
| REGN | Regeneron Pharma | $79B | +28.34% | -0.14% | +1.98% | 2.4 | Down | Up |
| ARGX | arGEN-X SpADR | $50B | +34.26% | -1.35% | +21.30% | 2.7 | Up | Up |
| ALNY | Alnylam Pharma | $41B | +30.28% | -15.60% | -1.20% | 4.1 | Down | Down |
| ONC | BeOne Medi Sp ADR | $35B | +23.56% | -8.59% | +13.45% | 2.9 | Down | Down |
| RVMD | REVOLUTION MEDIC | $31B | +303.96% | +26.69% | +55.46% | 4.3 | Up | Up |
| INSM | Insmed | $30B | +97.89% | -9.81% | +3.66% | 4.6 | Down | Down |
| NTRA | Natera | $29B | +42.04% | -15.39% | +5.19% | 4.9 | Neutral | Up |
| BNTX | BioNTech Sp ADR | $28B | +6.61% | -5.42% | +25.01% | 2.8 | Up | Up |
| BIIB | Biogen | $27B | +56.41% | +7.72% | +2.47% | 3.2 | Neutral | Up |
| UTHR | United Therapeut | $25B | +95.84% | +22.07% | +9.38% | 3.3 | Up | Up |
| MRNA | MODERNA | $22B | +110.68% | +8.87% | +5.55% | 5.1 | Up | Up |
| ROIV | ROIVANT SCIENCES | $21B | +181.09% | +27.46% | +5.74% | 3.2 | Up | Up |
| SMMT | SUMMIT THERAP | $20B | -3.55% | +56.56% | +70.08% | 5.5 | Up | Up |
| ILMN | Illumina | $20B | +77.51% | -13.44% | +6.15% | 3.9 | Up | Up |
| INCY | Incyte | $19B | +67.69% | -8.07% | +5.99% | 2.7 | Down | Up |
| GMAB | GENMAB SP ADR | $17B | +33.50% | -17.88% | +7.81% | 2.7 | Down | Down |
| ASND | Ascendis Sp ADR | $15B | +51.00% | +10.91% | +8.30% | 3.6 | Up | Up |
| BBIO | BRIDGEBIO PHARMA | $15B | +122.88% | -2.52% | +11.15% | 3.6 | Up | Up |
| MEDP | Medpace Holdings | $15B | +82.41% | -17.03% | +13.79% | 3.3 | Up | Neutral |
| NBIX | Neurocrine Biosc | $13B | +27.99% | -3.83% | +1.99% | 3.2 | Down | Down |
| IONS | Ionis Pharmaceut | $12B | +157.60% | -5.87% | +5.34% | 3.2 | Down | Up |
| MDGL | Madrigal Pharmct | $12B | +74.32% | +6.18% | +19.61% | 4.6 | Up | Up |
| EXEL | Exelixis | $12B | +25.79% | +2.41% | +11.19% | 2.7 | Up | Up |
| BMRN | Biomarin Pharm | $11B | -11.19% | -3.79% | +0.91% | 2.6 | Down | Down |
| ARWR | Arrowhead Phrmct | $9.9B | +474.84% | +5.10% | +26.13% | 4.8 | Up | Up |
| TEM | TEMPUS AI-A | $9.9B | +27.57% | -15.57% | +17.44% | 6.0 | Up | Down |
| PRAX | PRAXIS PRECIS | $9.5B | +847.30% | +9.03% | +14.26% | 5.7 | Up | Up |
| AXSM | Axsome Therapeut | $9.4B | +76.24% | -3.24% | +16.60% | 3.4 | Up | Up |
| TECH | Bio-Techne | $9.3B | +22.29% | -16.29% | +15.91% | 3.6 | Up | Neutral |
| CRL | Charles Riv Lab | $9B | +71.30% | -19.26% | +19.21% | 4.1 | Up | Up |
| ABVX | ABIVAX SP ADS | $8.8B | +1614.31% | -7.15% | -7.40% | 5.5 | Down | Up |
| PCVX | VAXCYTE | $8.7B | +93.70% | +20.57% | +10.65% | 3.9 | Up | Up |
| NUVL | NUVALENT-A | $8.4B | +50.06% | -1.75% | +13.04% | 3.5 | Up | Up |
| IBRX | IMMUNITYBIO | $8.4B | +201.12% | +17.05% | -4.37% | 9.7 | Neutral | Up |
| CYTK | Cytokinetics | $8.2B | +74.03% | +4.38% | +6.65% | 3.4 | Neutral | Up |
| HALO | Halozyme Therape | $8.1B | +17.52% | -4.60% | +7.85% | 2.7 | Neutral | Neutral |
| KRYS | KRYSTAL BIOTECH | $8B | +61.53% | -4.66% | +8.34% | 3.3 | Up | Up |
| 0 | 0 | 0 | 0 | Bullish | Bullish |